Page last updated: 2024-08-21

aminoimidazole carboxamide and ALS - Amyotrophic Lateral Sclerosis

aminoimidazole carboxamide has been researched along with ALS - Amyotrophic Lateral Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Horne, MK; Kemp, BE; Perera, ND; Scott, JW; Sheean, RK; Turner, BJ	1

Other Studies

1 other study(ies) available for aminoimidazole carboxamide and ALS - Amyotrophic Lateral Sclerosis

Article	Year
Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models. PloS one, 2014, Volume: 9, Issue:3 Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Amyotrophic Lateral Sclerosis; Animals; Brain; Cell Line; Disease Models, Animal; DNA-Binding Proteins; Enzyme Activation; Mice, Inbred C57BL; Mice, Transgenic; Motor Neurons; Mutant Proteins; Protein Phosphatase 2; Ribonucleotides; Spinal Cord; Superoxide Dismutase	2014

Article

Year

Mutant TDP-43 deregulates AMPK activation by PP2A in ALS models.

PloS one, 2014, Volume: 9, Issue:3

Topics: Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Amyotrophic Lateral Sclerosis; Animals; Brain; Cell Line; Disease Models, Animal; DNA-Binding Proteins; Enzyme Activation; Mice, Inbred C57BL; Mice, Transgenic; Motor Neurons; Mutant Proteins; Protein Phosphatase 2; Ribonucleotides; Spinal Cord; Superoxide Dismutase

2014